Purpose

The purpose of this study is to learn more about malignant colorectal polyps and the risk of the cancer remaining, coming back, or spreading after the polyp is removed. The researchers also want to understand how patients and doctors make decisions about treatment after a malignant polyp is removed. Additionally, the researcher will collect information medical records, including results from tests, imaging scans, lab work, and pathology reports. The researchers may also collect images from your colonoscopy and copies of pathology slides the polyp. The researchers will also follow the patient's health over time through regular doctor visits. If the patient does not have a scheduled visit, a member of the study team will contact the patient by phone at 1 year, 3 years, and 5 years after the patient joins the study to ask about their health.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Criteria

Criteria:

- Documentation of Disease

- Patients must have one malignant polyp, pathologically confirmed within 90 days of
enrollment. Patients with multiple malignant polyps are not eligible.

- Definition of Disease Colorectal carcinoma (CRC) develops within serrated or
adenomatous polyps. Early CRC represents invasion into the submucosa and frequently
presents within the precursor polyp which is termed a 'malignant polyp'(23).

The term malignant polyp specifically refers to a colorectal lesion with cancer invading
the submucosa but not extending into the muscularis propria. These lesions are classified
as pT1 in the TNM classification system (24)

Prior Treatment Endoscopic resection of the polypoid lesion-malignant polyp with simple
snare polypectomy, conventional endoscopic mucosal resection (EMR), or endoscopic
submucosal dissection (ESD) (25).

- Age ≥ 18

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey 07920
Contact:
Georgios Karagkounis, MD
212-639-2269

Memorial Sloan Kettering Monmouth
Middletown, New Jersey 07748
Contact:
Georgios Karagkounis, MD
212-639-2269

Memorial Sloan Kettering Bergen
Montvale, New Jersey 07645
Contact:
Georgios Karagkounis, MD
212-639-2269

Memorial Sloan Kettering Suffolk - Commack
Commack, New York 11725
Contact:
Georgios Karagkounis, MD
212-639-2269

Memorial Sloan Kettering Westchester
Harrison, New York 10604
Contact:
Georgios Karagkounis, MD
212-639-2269

Memorial Sloan Kettering Cancer Center
New York, New York 10065
Contact:
Georgios Karagkounis, MD
212-639-2269

Memorial Sloan Kettering Nassau
Uniondale, New York 11553
Contact:
Georgios Karagkounis, MD
212-639-2269

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Georgios Karagkounis, MD
212-639-2269
karagkog@mskcc.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.